Cannex Scientific

Cannex Scientific is a private biopharmaceutical company focused on discovering and developing cannabinoid-based therapeutics. The company has described a drug discovery approach centered on the endocannabinoid system, using advanced preclinical models and academic collaborations to identify nature-identical cannabinoid and terpene combinations with therapeutic potential. Publicly described areas of interest have included anxiety and other neurobiology-related conditions, gastroesophageal disorders, and lung injury associated with respiratory viruses. Cannex Scientific has highlighted collaborations with Brigham and Women's Hospital and Harvard-affiliated researchers to support translational development. Based on publicly available information, the company appears to remain at the preclinical research stage with no disclosed clinical-stage pipeline.